HAB Pharmaceuticals Charts Growth Path, Targets INR 2,500 to 3,000 Crore Revenue by 2030
HAB Pharmaceuticals is expanding its manufacturing and R&D capabilities while strengthening its specialty product portfolio and global regulatory footprint as it targets revenues of INR 2,500–3,000 crore by 2030.
Gastrointestinal Disorders | 29/07/2026 | By News Bureau
PENTAX Medical Sells C2 CryoBalloon Technology to Merit Medical Systems
PENTAX Medical, a division of the Japanese med-tech company HOYA Group and a global leader in flexible reusable endoscopy, has signed an asset purchase agreement with the American healthcare technology company Merit Medical Systems for the sale of its C2 CryoBalloon technology.
Gastrointestinal Disorders | 16/10/2025 | By Dineshwori | 244
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy